Compare
5 stocks, side by sideRelative performance · rebased to 100
RCUSRLAYNAMSCRNXDNLI
| RCUSArcus Biosciences, Inc. | RLAYRelay Therapeutics, Inc. | NAMSNewAmsterdam Pharma Company N.V. | CRNXCrinetics Pharmaceuticals, Inc. | DNLIDenali Therapeutics Inc. | |
|---|---|---|---|---|---|
| Smart Score | 6/10 | 7/10 | 3/10 | 9/10 | 2/10 |
| Price | $29.02 | $19.09 | $25.66 | $84.96 | $22.08 |
| 1 month | +2.2% | -3.1% | -7.1% | +1.3% | -11% |
| 1 year | +177% | +450% | +1.0% | +210% | +49% |
| 5 year | +5.8% | -42% | +165% | +384% | -58% |
| P/E (TTM) | -9.2 | -12.2 | -14.4 | -16.5 | -7.7 |
| P/E vs sector | - | - | - | - | - |
| Market cap | $3.8B | $3.9B | $3.7B | $3.7B | $3.9B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.